LSV Asset Management Sells 128,839 Shares of Centene Corporation $CNC

LSV Asset Management cut its position in shares of Centene Corporation (NYSE:CNC) by 2.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 4,433,225 shares of the company’s stock after selling 128,839 shares during the period. LSV Asset Management’s holdings in Centene were worth $158,177,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Mowery & Schoenfeld Wealth Management LLC bought a new position in Centene during the third quarter valued at $27,000. WPG Advisers LLC increased its stake in Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after acquiring an additional 282 shares during the last quarter. Bogart Wealth LLC lifted its stake in shares of Centene by 11,011.1% in the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after purchasing an additional 991 shares during the last quarter. Financial Network Wealth Advisors LLC lifted its position in Centene by 54.9% in the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after buying an additional 390 shares during the last quarter. Finally, Quent Capital LLC purchased a new stake in shares of Centene in the third quarter valued at $45,000. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene News Summary

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Deutsche Bank raised its price target to $39 (from $32) while keeping a “hold” rating — the PT bump improves near‑term sentiment and likely helped buying interest. Deutsche Bank Boosts PT to $39
• Positive Sentiment: TD Cowen raised its price target to $38 (maintaining a “hold”) — another upward revision that supports investor confidence even if the rating stays neutral. TD Cowen Raises PT to $38
• Positive Sentiment: Media/analyst write‑ups (Zacks/MSN) profile Centene as a long‑term value stock — such coverage can attract buy‑and‑hold investors and bolster demand. Zacks: Top Value Stock
• Neutral Sentiment: Cantor Fitzgerald reaffirmed a “neutral” rating, leaving analyst guidance unchanged. Cantor Fitzgerald Reaffirms Neutral
• Neutral Sentiment: Argus and Morgan Stanley maintained “hold/neutral” stances — multiple holds suggest limited near‑term upside from analyst action alone. Argus Upgrade to Hold Morgan Stanley Maintains Hold
• Neutral Sentiment: Superior HealthPlan (a Centene company) launched a school program addressing social isolation — positive PR/ESG impact but unlikely to move near‑term earnings. PR: No One Eats Alone
• Negative Sentiment: Axios reports Centene is among insurers to receive subpoenas from a House panel — this introduces regulatory and legal risk that could weigh on the stock if the inquiry deepens. Axios: House Panel Subpoenas

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on CNC shares. Mizuho set a $47.00 target price on Centene in a research note on Friday, January 9th. Barclays set a $44.00 price target on shares of Centene and gave the company an “equal weight” rating in a research note on Tuesday, November 4th. UBS Group set a $42.00 target price on Centene and gave the stock a “neutral” rating in a report on Thursday, October 30th. Jefferies Financial Group upped their price objective on shares of Centene from $25.00 to $32.00 in a research note on Monday, November 3rd. Finally, Zacks Research upgraded shares of Centene from a “strong sell” rating to a “hold” rating in a research note on Wednesday, October 29th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $41.50.

Centene Stock Up 2.1%

NYSE:CNC opened at $40.43 on Thursday. The company has a current ratio of 1.10, a quick ratio of 1.08 and a debt-to-equity ratio of 0.87. Centene Corporation has a twelve month low of $25.08 and a twelve month high of $66.03. The company has a market cap of $19.87 billion, a PE ratio of -2.97, a P/E/G ratio of 0.87 and a beta of 0.48. The company’s 50 day moving average is $42.08 and its two-hundred day moving average is $36.18.

Centene (NYSE:CNC) last issued its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The company had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. During the same quarter last year, the business posted $0.80 EPS. The firm’s quarterly revenue was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Analysts anticipate that Centene Corporation will post 6.86 EPS for the current year.

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.